Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Overactive Bladder Syndrome

In brief

A single site, double-blinded, randomized controlled trial for postmenopausal women with urinary frequency, urgency, nocturia with or without urgency urinary incontinence symptoms. Patient's will be randomized between 0.01% vaginal estradiol cream with placebo oral pill or daily 50 milligrams oral Mirabegron with a placebo vaginal cream for 12 weeks.

Key facts

Study ID
NCT05221021
Run by
Walter Reed National Military Medical Center
People needed
152
Starts
2022-10-01
Expected to finish
2027-01-30
Last updated by the study team
2024-08-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.